language_icon
EN
HI

Healthcare Global Enterprises Share price

HCG

608.15

12.45 (-2.01%)
NSE
BSE
Last updated on 7 May, 2026 | 09:36 IST
Today's High

624.85

Today's Low

608.15

52 Week Low

513.30

52 Week High

796.68

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Healthcare Global Enterprises Chart

Healthcare Global Enterprises Share Key Metrics

Volume
48087.00
Market Cap
9265.69 CR
LTQ@LTP
2@608.15
ATP
613.59
Var Margin
16.27 %
Circuit Range
496.5-744.7
Delivery %
49.3 %
Value
2.95 CR
ASM/GSM
No
Market Lot
1

Summary

Healthcare Global Enterprises share price stands at ₹608.15 at 7 May, 2026 | 09:36. The stock Healthcare Global Enterprises intraday movement has stayed between ₹608.15 and ₹624.85, while on a 52-week basis it has fluctuated from ₹513.30 to ₹796.68.
In terms of trading activity, Healthcare Global Enterprises has recorded a volume of 48087 shares. The Healthcare Global Enterprises has a market cap of ₹149302204. The stock’s Average Traded Price (ATP) stands at ₹61359, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2, 60815.
The Healthcare Global Enterprises operates within a circuit range of ₹496.5-744.7 – ₹496.5-744.7, with a Value of ₹2.95 CR. The Delivery Percentage for the day is 49.3%. Additionally, Healthcare Global Enterprises currently falls under the No framework, and trades with a market lot size of 1.

Healthcare Global Enterprises Fundamentals

View More
P/E Ratio

488.95

P/B Ratio

6.93

Div. Yield

0

Sector P/E

56.08

Sector P/B

-15.89

Sec. Div. Yield

1.86

Healthcare Global Enterprises Resistance and Support

Pivot 623.42

Resistance

First Resistance

633.84

Second Resistance

647.07

Third Resistance

657.49

Support

First Support

610.19

Second Support

599.77

Third Support

586.54

Healthcare Global Enterprises Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

64.21%

Mutual Fund

15.31%

Insurance

0.58%

Foreign Institutional Investors

2.76%

Domestic Institutional Investors

3.01%

Retail

14.13%

Others

0%

Total Promoters
MAR '26
64.21%

Healthcare Global Enterprises Corporate Actions

DateAgenda
2026-05-19Audited Results
2026-02-17Rights issue of Equity Shares
2026-02-05Quarterly Results
2025-11-12Quarterly Results
2025-08-01Quarterly Results
2025-05-24Audited Results
2025-02-14Quarterly Results & Others
2025-02-13Quarterly Results & Others

Healthcare Global Enterprises News

Healthcare Global Enterprises Limited

HealthCare Global's Board is scheduled to meet on May 19, 2026, to consider and approve the audited financial results for Q4 FY26. This is a routine meeting to finalize the company's financial performance.
May 01 2026 12:05:00

HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Considering And Approving Inter-Alia, The Audited Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended March 31, 2026 ('Financial Results').

Healthcare Global Enterprises' Board of Directors is scheduled to meet on May 19, 2026. The meeting's agenda includes considering and approving the audited financial results for the quarter and financial year ended March 31, 2026.
May 01 2026 12:05:00

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

HealthCare Global completed acquisition of an additional 34% equity in Vizag Hospital for ₹154.50 crores. This increases their total stake to 85% in Vizag Hospital and Cancer Research Centre.
Apr 13 2026 19:04:00

Healthcare Global Enterprises Limited

HealthCare Global Enterprises completed the acquisition of an additional 34% equity in Vizag Hospital for ₹154.50 crore. This increases the company's total holding in Vizag Hospital to 85%, solidifying its presence in the healthcare sector.
Apr 13 2026 19:04:00
Read More

About Healthcare Global Enterprises

NSE : 15555  
BSE : 539787  
ISIN : INE075I01017  

The Company was originally incorporated as Curie Centre of Oncology Private Limited on March 12 1998 at Bengaluru Karnataka India as a private limited company under the Companies Act 1956. The name of the Company was subsequently changed to HealthCare Global Enterprises Private Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on November 14 2005. the Company was converted into a public limited company pursuant to a special resolution passed by the Shareholders at the EGM held on May 20 2006 and the name of the Company was changed to HealthCare Global Enterprises Limited. A fresh certificate of incorporation consequent upon conversion to a public limited company was issued by the RoC on July 5 2006. Major events and milestones of the Company :2005-Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited 2006-India Development Fund made its first investment of 500 million in the Company -BMORCL became the Subsidiary 2007-HCG Medi-Surge became the Subsidiary -Evolvence made its first investment of 225 million in the Company 2008-NTICPL made its first investment of 400 million in the Company 2009-Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company 2010-IL&FS Trust Company Limited a/c MPEF through its scheme India Build Out Fund I and MAT made its first investment of 312 million in the Company 2011-Amalgamation of BMORCL with the Company -PIOF became a Shareholder by purchasing shares from NTICPL 2013-V-Sciences made its first investment of `600 million in the Company -Entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare 2014-Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company 2015-HCG Regency became the Subsidiary -Amalgamation of HCG Vijay with the Company

Read More

Healthcare Global Enterprises Management

NamePosition
Sunu ManuelCompany Secretary & Compliance Officer
B S Ajai KumarChairman
View More

Healthcare Global Enterprises FAQs

The Buying Price of Healthcare Global Enterprises share is 608.15 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Healthcare Global Enterprises stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Healthcare Global Enterprises, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Healthcare Global Enterprises shares is 488.95. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Healthcare Global Enterprises shares is 6.93. Useful to assess the stock's value relative to its book value.

To assess Healthcare Global Enterprises’s valuation compare Sector P/E, P/B which are 56.08 & -15.89 with sector averages, along with growth rates and financial metrics.

The Market Cap of Healthcare Global Enterprises is 9265.69 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Healthcare Global Enterprises share price is 796.68 & 513.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Healthcare Global Enterprises belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost